Status:
COMPLETED
Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This is an out-patient based prospective, multi-centre, observational post-marketing surveillance study amongst internists and cardiologists. In this study, patients with essential hypertension and at...
Detailed Description
Purpose:
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male or female of age 18 years or older;
- Newly diagnosed and untreated or previously treated and uncontrolled patients with essential hypertension;
- Seated blood pressure of \>140/90 mmHg or \>130/80 mmHg in patients with diabetes mellitus or chronic kidney disease;
- Patients with at least one cardiovascular (cv) risk factor;
- Ability to provide written informed consent.
- Exclusion criteria:
- Patients with contraindications to the prescribed antihypertensive medications;
- Pregnant or lactating women or women of childbearing potential not using an acceptable method of contraception;
- Patients who are participating in any other study protocol.
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
1674 Patients enrolled
Trial Details
Trial ID
NCT01853839
Start Date
October 1 2011
End Date
July 1 2014
Last Update
August 10 2015
Active Locations (132)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 106
Algiers, Algeria
2
Boehringer Ingelheim Investigational Site 107
Algiers, Algeria
3
Boehringer Ingelheim Investigational Site 108
Algiers, Algeria
4
Boehringer Ingelheim Investigational Site 109
Algiers, Algeria